Simple Measures to Monitor b -Cell Mass and Assess Islet Graft Dysfunction

Autor: Faradji, RN, Monroy, K, Messinger, S, Pileggi, A, Froud, T, Baidal, DA, Cure, PE, Ricordi, C, Luzi, L, Alejandro, R ^*

Publikováno v: In American Journal of Transplantation February 2007 7(2):303-308

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study.

Autor: Al Ozairi E; DAFNE Unit, Department of Clinical Research and Clinical Trials, Dasman Diabetes Institute, Dasman, Kuwait., Steenackers N; Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium., Pazmino S; Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium., Alattar AT; DAFNE Unit, Department of Clinical Research and Clinical Trials, Dasman Diabetes Institute, Dasman, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait., Al Kandari J; DAFNE Unit, Department of Clinical Research and Clinical Trials, Dasman Diabetes Institute, Dasman, Kuwait.; Amiri Hospital, Ministry of Health, Kuwait., Almeda-Valdes P; Departamento de Endocrinología y Metabolismo, Unidad de Investigación de Enfermedades Metabólicas Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Antonio-Villa NE; Departamento de Endocrinología, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico., Delfin C; Department of Pharmacometrics, Novo Nordisk A/S, Søborg, Denmark., Faradji RN; Endocrinology and Diabetes, Clinica EnDi, Mexico City, Mexico.; Endocrinology and Diabetes, Centro Medico ABC, Mexico City, Mexico., García-Tuomola A A; Endocrinology and Diabetes, Centro Medico ABC, Mexico City, Mexico., Irshad M; DAFNE Unit, Department of Clinical Research and Clinical Trials, Dasman Diabetes Institute, Dasman, Kuwait., Longenecker JC; Department of Epidemiology and Biostatistics, Drexel University Dornsife School of Public Health, Philadelphia, USA., Rosen J; Breakthrough T1D International, New York, NY, USA., Hurtado Del Pozo C; Breakthrough T1D International, New York, NY, USA., Sparsø T; Department of Pharmacometrics, Novo Nordisk A/S, Søborg, Denmark., Lavens A; Health Services Research, Sciensano, Brussels, Belgium., Mathieu C; Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.; Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium., Van der Schueren B; Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.; Department of Endocrinology, University Hospitals Leuven, Leuven, Belgium., le Roux CW; Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.

Publikováno v: EClinicalMedicine [EClinicalMedicine] 2024 Oct 03; Vol. 77, pp. 102869. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).